| Revista: | Journal of technology management & innovation |
| Base de datos: | CLASE |
| Número de sistema: | 000331161 |
| ISSN: | 0718-2724 |
| Autores: | Oliveira, Leandra Guimaraes de Carestiato, Tatiana1 Mothe, Cheila Goncalves2 Souza, Raimundo Vicente de3 |
| Instituciones: | 1Instituto Nacional da Propriedade Industrial, Rio de Janeiro. Brasil 2Universidade Federal do Rio de Janeiro, Departamento de Engenharia Quimica, Rio de Janeiro. Brasil 3Universidade Federal de Lavras, Fundacao de Apoio ao Ensino, Pesquisa e Extensao, Lavras, Minas Gerais. Brasil |
| Año: | 2010 |
| Volumen: | 5 |
| Número: | 3 |
| Paginación: | 110-119 |
| País: | Chile |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Analítico, descriptivo |
| Resumen en inglés | The current study intends to present the relevance of omeprazole, esomeprazole, rabeprazole, pantoprazole and lansoprazole by means of the technological foresight study, through invention patent documents from Brazilian applicants as indicators of innovation. The European database of patents (Espacenet), Word Patent Index (DERWENT) and the Brazilian Patent Base of INPI were used, combining keywords and International Patent Classifications. The major applicants, countries of publication and claims categories were mapped. The 212 patent requests collected are mainly distributed in Chemistry, Pharmacy and Pharmacology areas. The results obtained revealed that the US was the main country with studies directed to this technological area (59 patent applications) and the major applicant was the company Astrazeneca AB. Therefore, we can understand that this is a promising technology that may reflect in an increase of R&D activities and patent applications in this area |
| Disciplinas: | Economía |
| Palabras clave: | Empresas, Brasil, Industria farmacéutica, Patentes, Omeprazol, Investigación y desarrollo, monitoreo |
| Texto completo: | Texto completo (Ver HTML) |
